Guangzhou Institutes of Biomedicine and Health (GIBH) was established in 2003 by the Chinese Academy of Sciences in partnership with the City of Guangzhou and the Province of Guangdong. GIBH is located at 190 Kai Yuan Avenue, Science Park, which is a newly constructed campus with five buildings containing state of the art, fully equipped research laboratories. Currently, the institute employs approximately 350 staff members as well as mentors 230 students with an annual operating budget of $20M. Unlike other institutes throughout China, in addition to championing basic science and academic exploration, a primary objective for GIBH is drug discovery research and the advancement of new therapeutics into clinical trials. The mission of GIBH is to serve the citizens of China and the world through discovery, learning and engagement by integrating both biological and chemical sciences for the improvement of human health.GIBH consists of three primary departments including: (1) Stem Cell Biology & Regenerative Medicine (iSCBRM); (2) Chemical Biology (iCB); and (3) Infection & Immunity (I3). Additionally, a new Drug Discovery Pipeline (DDP) was created in 2009 to broaden the benefit from the core departments and to promote applied science with an emphasis on drug development.